Tadashi Hasegawa
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Successful Methods for Switching from a Benzodiazepine Receptor Agonist to a Dual Orexin Receptor Antagonist for the Treatment of Insomnias.
Journal: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
Published: March 05, 2025
A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Published: December 08, 2023
New treatment strategy for chronic low back pain with alpha wave neurofeedback.
Journal: Scientific reports
Published: June 11, 2022
Reliability and validity of the Japanese version of the 4A's Test for delirium screening in the elderly patient.
Journal: Asian journal of psychiatry
Published: June 01, 2021
Cyclothymic Temperament is Associated with Poor Medication Adherence and Disordered Eating in Type 2 Diabetes Patients: A Case-Control Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 18, 2021
Possible effect of blonanserin on gambling disorder: A clinical study protocol and a case report.
Journal: World journal of clinical cases
Published: December 14, 2020
Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR.
Journal: Journal of psychiatric research
Published: August 04, 2020
Autistic traits and cognitive profiles of treatment-resistant schizophrenia.
Journal: Schizophrenia research. Cognition
Published: April 14, 2020
Identifying improvable employment-related factors in schizophrenia patients.
Journal: Psychiatry research
Published: July 25, 2017
Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial.
Journal: Annals of general psychiatry
Published: July 14, 2016
Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study.
Journal: Neuropsychiatric disease and treatment
Published: December 18, 2015
Last Updated: 09/26/2026